METHOD AND DEVICE FOR COMPLETING SOCIAL NETWORK USING ARTIFICIAL NEURAL NETWORK

    公开(公告)号:US20210110242A1

    公开(公告)日:2021-04-15

    申请号:US16900609

    申请日:2020-06-12

    摘要: A method and device for completing a social network using an artificial neural network are disclosed. The disclosed device includes: a neural network unit configured to receive a target network having unrevealed missing nodes as input, infer the connections of the missing nodes with a neural network, and output multiple candidate complete networks according to various node sequences; and a selection unit configured to select one of the candidate complete networks outputted by the neural network unit, where the neural network unit outputs the candidate complete networks by using weights of a graph-generating neural network that has learned graph structures of reference networks having attributes similar to those of the target network, and the selection unit uses connection probability vectors obtained from the learned graph-generating neural network to select the candidate complete network probabilistically having a structure closest to that of the target network based on the connection probability vectors.

    Universal influenza vaccine using cold-adapted live-attenuated virus

    公开(公告)号:US10953086B2

    公开(公告)日:2021-03-23

    申请号:US16265132

    申请日:2019-02-01

    摘要: Disclosed is a universal influenza vaccine composition and corresponding methods comprising at least one attenuated live-attenuated influenza vaccine. The vaccine composition can exhibit a cross-protective effect against a wide range of influenza viruses and can ensure a strong protection efficacy, a wide range of protection, and safety. In addition, a vaccination method of heterologous live vaccines of the present invention induces various immunological effects so that cross-immunogenicity and cross-protective ability are remarkably increased, and thus is expected to be usefully utilized as a universal influenza prevention method. A person who has a basal immunity through infection with an influenza virus or vaccination with an influenza vaccine can be regarded as being in a state where primary vaccination has already been performed, single vaccination with a live vaccine induces an enhanced cross-immune response, and thus it is possible to expect a wide range of protective effects against various viruses.